• SU 5402 for Reliable Cell Assays

  2026-09-15

  A scenario-driven guide to using SU 5402 (SKU A3843) in viability, proliferation, apoptosis, and receptor tyrosine kinase studies. It connects target-level potency, solvent handling, orthogonal readouts, and vendor-selection criteria to improve interpretation and reproducibility.

• DIDS: Practical Workflows for Chloride and Cancer Studies

  2026-09-14

  DIDS combines chloride-transport inhibition with context-dependent effects on TRPV1, vascular tone, mitochondrial membrane permeabilization, and tumor-cell stress. This guide translates those properties into assay-ready workflows, controls, troubleshooting decisions, and a cautious strategy for studying prometastatic states after near-death stress.

• Pertussis toxin: Applied cAMP Research Workflows

  2026-09-14

  Use Pertussis toxin as a controlled perturbation tool for cAMP signaling, dendritic-cell maturation, and selected Gαi/o-sensitive behavioral assays. This workflow-oriented guide distinguishes literature-backed applications from optimization steps, helping researchers interpret immune, vascular, and neurobehavioral readouts without overgeneralizing across models.

• HyperScribe™ mRNA Kit: From Cap to Immune Readout

  2026-09-13

  The HyperScribe All in One mRNA Synthesis Kit Plus 1 enables ARCA-capped, modified, polyadenylated mRNA production for translation and RNA vaccine research. This guide connects its chemistry to assay design, immune-response interpretation, and the spleen-targeted neoantigen vaccine findings reported in Cell Reports Medicine.

• Tiamulin (Thiamutilin): Applied Research Workflows

  2026-09-12

  Tiamulin combines targeted antibacterial activity with investigational anti-inflammatory effects, making it useful for pathogen assays, veterinary pharmacology, residue analysis, and pathway-focused cell studies. This workflow-centered guide shows how to prepare, test, troubleshoot, and interpret Tiamulin data across bacterial, animal, and translational models.

• TAK1–YAP Control of Gastric Cancer Stem Cells

  2026-09-11

  The reference study identifies TGFβ-activated kinase 1 (TAK1) as an inflammatory, stemness-promoting regulator in gastric cancer. Its key mechanistic contribution is linking IL-6-driven TAK1 expression to stabilization of YAP, increased SOX2 and SOX9 transcription, gastric cancer stem-cell self-renewal, and tumorigenesis.

• SMYD2, miR-125b, and Drug Resistance in RCC

  2026-09-11

  The reference study identifies SMYD2 as an epigenetic driver of clear cell renal cell carcinoma progression and multidrug resistance, linking SMYD2 to miR-125b, DKK3, and P-glycoprotein regulation. Its combination of patient-prognostic analysis, molecular perturbation, drug-response testing, and xenograft validation provides a mechanistic framework for studying treatment resistance in RCC.

• Cy5.5 NHS ester Workflows for Hydrogel Imaging

  2026-09-10

  Build a practical labeling and imaging workflow around Cy5.5 NHS ester (non-sulfonated) to quantify biomolecule retention, hydrogel localization, and delivery performance. The approach connects near-infrared fluorescence imaging with the bioadhesive miR-140 hydrogel strategy reported in aged osteoarthritis research, while addressing solvent, purification, and signal-interpretation risks.

• GW4064, FXR Signaling, and NiONP-Induced Fibrosis

  2026-09-10

  The reference study identifies hsa_circ_0001944 as a regulatory node connecting FXR, TLR4, ferroptosis, and collagen deposition in nickel oxide nanoparticle-exposed hepatic stellate cells. Its use of GW4064 alongside pathway inhibitors, a ferroptosis inducer, and circRNA overexpression provides pharmacological and molecular evidence that FXR activation may restrain toxicant-associated fibrogenic responses.

• Palomid 529 (P529) for ESCC Research

  2026-09-09

  Palomid 529 (P529) gives researchers a practical way to interrogate PI3K/Akt/mTOR signaling in esophageal squamous cell carcinoma, including cisplatin resistance, metastasis, angiogenesis, and radiotherapy response. Its dual mTORC1/mTORC2 activity also supports mechanism-focused combination assays when paired with genetic controls and carefully optimized exposure conditions.

• Erlotinib Workflows for EGFR Research

  2026-09-09

  Erlotinib, also known as NSC 718781, provides a practical way to quantify EGFR kinase suppression in biochemical and cell-based cancer models. This guide connects reproducible EGFR assays with SCUBE3-driven resistance biology, offering workflow parameters, assay-selection guidance, and troubleshooting strategies.

• MK-571: Linking Leukotriene Signaling to Drug Resistance

  2026-09-08

  MK-571 (L-660,711) is best understood not only as a cysteinyl leukotriene receptor antagonist, but also as a strategic probe for separating airway inflammation from transporter and redox biology. This article connects its established cysLT1 pharmacology with recent macrophage findings involving system Xc−, glutathione, and ABCC1, while outlining validation strategies that reduce interpretive ambiguity in translational studies.

• DIDS: A Mechanism-Aware Research Guide

  2026-09-08

  DIDS is more than a chloride channel blocker: its value depends on separating ion-transport pharmacology from context-dependent cell-death biology. This guide translates DIDS data into practical assay decisions, with special attention to metastasis models, TRPV1 channel modulation, vascular studies, and experimental controls.

• NHE1, Olfr2, and Calcium-Driven Atherosclerosis

  2026-09-07

  This Scientific Reports study identifies macrophage NHE1 as a downstream effector of octanal–Olfr2 signaling in atherosclerosis, linking calcium-dependent oxidative stress with NLRP3-associated inflammation. By combining ApoE−/− mice, RAW264.7 macrophages, pharmacological inhibition, RNA interference, and calcium chelation, the work strengthens a mechanistic model in which NHE1 contributes to plaque formation and inflammatory activation.

• EGF-Driven Migration Without EMT in A549 Cells

  2026-09-07

  The reference study separates epidermal growth factor-driven migration from epithelial–mesenchymal transition and invasion in A549 lung adenocarcinoma cells. Its combined imaging, pathway, transcript, protein, and proteomic analyses show that EGF and TGFβ can produce similar motility while relying on different kinetics and molecular programs.

8541 records 1/570 page Next 12345 下5页 Last page